Walleye Capital’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

Walleye Capital’s Portfolio CMRAW Stock Details CMRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-61,955	Closed	-$1.34K	–	5750
2023 Q3	$1.34K	Hold	61,955	–	–	﹤0.01%	4744
2023 Q2	$1.68K	Hold	61,955	–	–	﹤0.01%	4166
2023 Q1	$2.67K	Hold	61,955	–	–	﹤0.01%	3739
2022 Q4	$2.96K	Hold	61,955	–	–	﹤0.01%	2933
2022 Q3	$4K	Hold	61,955	–	–	﹤0.01%	2981
2022 Q2	$9K	Buy	+61,955	New	+$10.1K	﹤0.01%	2035

Other funds holding CMRAW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Walleye Capital's CMRAW Position: Q4 2023 in Review

Walleye Capital sold out of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) in Q4 2023, closing a stake of 61,955 shares — an estimated $1.34K sold.

Walleye Capital first reported a position in CMRAW in Q2 2022 and held it in 6 quarters. The position peaked at $9K in Q2 2022. 3 funds tracked by Wall St. Rank hold CMRAW as of Q4 2023.

Walleye Capital reported no remaining Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position as of Q4 2023 after selling out during the quarter.
Walleye Capital sold 61,955 Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 shares in Q4 2023, an estimated $1.34K.
Walleye Capital first reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in Q2 2022 and held it in 6 quarters.
Walleye Capital's Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position peaked at $9K in Q2 2022.
3 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.